FRIDAY, Aug. 13, 2021 (HealthDay News) — Black American liver transplant recipients have a lower survival rate than Hispanic or white patients, and a new study suggests that alcohol-related liver disease and insurance coverage are key reasons. “Our findings are a huge wake-up call that physicians and other health careContinue Reading

THURSDAY, Aug. 12, 2021 (HealthDay News) — A third dose of a two-shot COVID vaccine significantly boosts transplant patients’ protection against SARS-CoV-2, according to a new study. “We knew from previous studies that two doses were not enough to produce a good immune response against COVID-19 in transplant patients,” saidContinue Reading

WEDNESDAY, July 7, 2021 (HealthDay News) — COVID-19 vaccinations may not offer as much protection to people with compromised immune systems, but just how much appears to be driven by the type of underlying condition, new research suggests. “People with conditions that compromise their immune systems exhibit a wide spectrumContinue Reading

TUESDAY, June 29, 2021 (HealthDay News) — Early research suggests that CRISPR gene-editing technology may some day lead to dramatic relief for patients struggling with amyloidosis, a rare but serious disease that can trigger organ failure. “There are many different types of amyloidosis,” explained study author Dr. Julian Gillmore, aContinue Reading

TUESDAY, June 22, 2021 (HealthDay News) — Want to be good to your liver? Pour yourself another cup o’ joe. British researchers report that coffee of all kinds may reduce your risk for chronic liver disease. Whether your java jolt is caffeinated or decaffeinated, ground or instant, makes no differenceContinue Reading